300147 Stock Overview
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Xiangxue Pharmaceutical Co.,Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.58 |
| 52 Week High | CN¥6.45 |
| 52 Week Low | CN¥3.00 |
| Beta | 0.69 |
| 1 Month Change | -14.15% |
| 3 Month Change | -23.34% |
| 1 Year Change | -33.21% |
| 3 Year Change | -53.45% |
| 5 Year Change | -51.82% |
| Change since IPO | -62.86% |
Recent News & Updates
Shareholder Returns
| 300147 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 0.3% | 0.8% | -0.4% |
| 1Y | -33.2% | -13.4% | -14.4% |
Return vs Industry: 300147 underperformed the CN Pharmaceuticals industry which returned -12.9% over the past year.
Return vs Market: 300147 underperformed the CN Market which returned -15.1% over the past year.
Price Volatility
| 300147 volatility | |
|---|---|
| 300147 Average Weekly Movement | 10.9% |
| Pharmaceuticals Industry Average Movement | 7.7% |
| Market Average Movement | 8.8% |
| 10% most volatile stocks in CN Market | 12.7% |
| 10% least volatile stocks in CN Market | 5.2% |
Stable Share Price: 300147's share price has been volatile over the past 3 months.
Volatility Over Time: 300147's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 2,417 | Yonghui Wang | www.xphcn.com |
Xiangxue Pharmaceutical Co., Ltd. engages in the research and development, procurement, manufacture, delivery, and distribution of pharmaceutical products in China. It offers antivirotic oral liquids under the Xiangxue brand name; and healthcare supplements, as well as health solutions, such as food and beverage. Xiangxue Pharmaceutical Co., Ltd.
Xiangxue Pharmaceutical Co.,Ltd. Fundamentals Summary
| 300147 fundamental statistics | |
|---|---|
| Market cap | CN¥2.37b |
| Earnings (TTM) | -CN¥380.57m |
| Revenue (TTM) | CN¥2.17b |
1.1x
P/S Ratio-6.2x
P/E RatioIs 300147 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 300147 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.17b |
| Cost of Revenue | CN¥1.44b |
| Gross Profit | CN¥727.25m |
| Other Expenses | CN¥1.11b |
| Earnings | -CN¥380.57m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
Apr 27, 2024
| Earnings per share (EPS) | -0.58 |
| Gross Margin | 33.52% |
| Net Profit Margin | -17.54% |
| Debt/Equity Ratio | 91.1% |
How did 300147 perform over the long term?
See historical performance and comparison